Guido Marcucci
Guido Marcucci
Verified email at
Cited by
Cited by
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
M Fabbri, R Garzon, A Cimmino, Z Liu, N Zanesi, E Callegari, S Liu, ...
Proceedings of the National Academy of Sciences 104 (40), 15805-15810, 2007
Targeting microRNAs in cancer: rationale, strategies and challenges
R Garzon, G Marcucci, CM Croce
Nature reviews Drug discovery 9 (10), 775-789, 2010
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia
KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ...
New England journal of medicine 371 (11), 1005-1015, 2014
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ...
New England Journal of Medicine 377 (5), 454-464, 2017
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly …
R Garzon, S Liu, M Fabbri, Z Liu, CEA Heaphy, E Callegari, S Schwind, ...
Blood, The Journal of the American Society of Hematology 113 (25), 6411-6418, 2009
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
G Marcucci, K Maharry, YZ Wu, MD Radmacher, K Mrózek, D Margeson, ...
Journal of clinical oncology 28 (14), 2348, 2010
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular …
K Mrozek, G Marcucci, P Paschka, SP Whitman, CD Bloomfield
Blood 109 (2), 431-448, 2007
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia
R Garzon, S Volinia, CG Liu, C Fernandez-Cymering, T Palumbo, ...
Blood, The Journal of the American Society of Hematology 111 (6), 3183-3189, 2008
Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study
P Paschka, G Marcucci, AS Ruppert, K Mrózek, H Chen, RA Kittles, ...
Journal of Clinical Oncology 24 (24), 3904-3911, 2006
Fundamentals of phase-only liquid crystal on silicon (LCOS) devices
Z Zhang, Z You, D Chu
Light: Science & Applications 3 (10), e213, 2014
Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications
G Marcucci, T Haferlach, H Döhner
Journal of Clinical Oncology 29 (5), 475-486, 2011
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts
AM Eiring, JG Harb, P Neviani, C Garton, JJ Oaks, R Spizzo, S Liu, ...
Cell 140 (5), 652-665, 2010
MicroRNA fingerprints during human megakaryocytopoiesis
R Garzon, F Pichiorri, T Palumbo, R Iuliano, A Cimmino, R Aqeilan, ...
Proceedings of the National Academy of Sciences 103 (13), 5078-5083, 2006
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
P Neviani, R Santhanam, R Trotta, M Notari, BW Blaser, S Liu, H Mao, ...
Cancer cell 8 (5), 355-368, 2005
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine
W Blum, R Garzon, RB Klisovic, S Schwind, A Walker, S Geyer, S Liu, ...
Proceedings of the National Academy of Sciences 107 (16), 7473-7478, 2010
MicroRNA expression in cytogenetically normal acute myeloid leukemia
G Marcucci, MD Radmacher, K Maharry, K Mrózek, AS Ruppert, ...
New England Journal of Medicine 358 (18), 1919-1928, 2008
MicroRNA 29b functions in acute myeloid leukemia
R Garzon, CEA Heaphy, V Havelange, M Fabbri, S Volinia, T Tsao, ...
Blood 114 (26), 5331-5341, 2009
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia
JC Byrd, G Marcucci, MR Parthun, JJ Xiao, RB Klisovic, M Moran, TS Lin, ...
Blood 105 (3), 959-967, 2005
Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia
K Mrózek, G Marcucci, D Nicolet, KS Maharry, H Becker, SP Whitman, ...
Journal of clinical oncology 30 (36), 4515, 2012
Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study
V Goede, K Fischer, A Engelke, R Schlag, S Lepretre, LFC Montero, ...
Leukemia 29 (7), 1602-1604, 2015
The system can't perform the operation now. Try again later.
Articles 1–20